Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226352 | SCV000290267 | likely benign | Adams-Oliver syndrome 5 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001170713 | SCV000319510 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-11-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001572783 | SCV000532277 | likely benign | not provided | 2020-09-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28991257) |
Eurofins Ntd Llc |
RCV000121694 | SCV000862405 | benign | not specified | 2018-07-11 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170713 | SCV001333314 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000226352 | SCV002555156 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269863 | SCV002555157 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121694 | SCV004029541 | likely benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001572783 | SCV004162064 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | NOTCH1: BS1, BS2 |
ITMI | RCV000121694 | SCV000085892 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Laboratory of Diagnostic Genome Analysis, |
RCV001572783 | SCV001797681 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001572783 | SCV001807343 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572783 | SCV001974183 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004530027 | SCV004741682 | likely benign | NOTCH1-related disorder | 2019-03-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |